Hypochlorous Acid
In clinical developmentAlso known as Chlor(I)-säure, Chloranol, Hydroxidochlorine, Hypochlorige Säure.
Recent clinical, regulatory, research and industry developments relating to this drug.
ROS signaling in innate immunity via oxidative protein modifications.
Comparative Study of Two Antiseptics Solutions for the Prevention of Surgical Site Infection
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Frontiers in immunology1
- Kzhyshkowska J1
- Manoharan RR1
- Pospíšil P1
- Prasad A1
- Institute of Transfusion Medicine and Immunology1
- Laboratory of Genetic Technologies1
- Laboratory of Translational Cellular and Molecular Biomedicine1
- Palacký University1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Frequently co-studied with Hypochlorous Acid in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials